Searched for
PFIZER BIONTECH MRNA
GSK set to get $500 million from settlement of mRNA lawsuitCureVac NV has settled its US patent dispute with Pfizer and BioNTech SE regarding mRNA vaccines, resulting in GSK receiving up to $500 mil...- GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technologyGlaxoSmithKline (GSK) has filed a lawsuit against Pfizer and BioNTech in Delaware federal court, alleging infringement of GSK's patents rel...
- Sanofi says it's back to the drawing board on mRNA flu vaccinesSanofi, one of the top global vaccine makers, has stated that the current mRNA technology used in COVID-19 vaccines is not effective agains...
- Could cancer vaccines become a reality? Here’s what experts sayA cancer vaccine could be a reality in a few years, according to the co-founders of BioNTech, a German company, which also manufactured the...
- Moderna sues Pfizer/BioNTech for patent infringement over COVID vaccineModerna alleges Pfizer/BioNTech, without permission, copied mRNA technology that Moderna had patented between 2010 and 2016, well before CO...
- Amid Covid vaccine success, BioNTech plans to return €2bn to shareholdersAfter the success of the covid vaccine, BioNTech is planning to return €2bn to shareholders. BioNTech will continue the clinical trial to b...
- The Covid vaccine helped world resume a sense of normalcy. Will it bag the Nobel Medicine Prize on Monday?Katalin Kariko and Drew Weissman are being seen as potential winners.
- BioNTech shot produces 10x more antibodies than Sinovac: StudyThe research, published in The Lancet, found that antibody levels among Hong Kong health workers who have been fully vaccinated with BioNTe...
- A cure for cancer: After Covid vaccine, next mRNA miracle might be closer than you imagineThe new technology was not only lightning fast but also incredibly effective - mRNA Covid vaccines from both Moderna and Pfizer hit the bul...
- Not in talks with local companies to make vaccine in India: PfizerVarious governments, WHO and others have been pushing vaccine makers to transfer technology to companies in Asia and Africa to scale up pro...
- Countries seek more Moderna, Pfizer/BioNTech shots as concerns mount over rival vaccinesCountries in Europe and Asia, as well as South Africa, are limiting or halting use of AstraZeneca's shot over safety concerns. Rollout of J...
- EU seeks new contract with Pfizer/BioNTech for up to 1.8 bln vaccines from 2022: EU sourceThe EU official, who asked not to be named because the matter is confidential, said the EU executive had already decided to approach Pfizer...
- Pfizer, Moderna COVID-19 vaccines highly effective even after first shot in real-world useThe study by the U.S. Centers for Disease Control and Prevention (CDC) evaluated the vaccines' ability to protect against infection, includ...
- Pfizer to develop new vaccines on its own using mRNA technologyThe drugmaker said it was ready to pursue mRNA on its own following its experience in the past year working on the COVID-19 vaccine, the WS...
- Pfizer sees $15 billion in 2021 sales from COVID-19 vaccinePfizer said it had supplied 65 million doses globally and 29 million doses in the United States as of Jan. 31. It expects to supply 200 mil...
- Pfizer-BioNTech say Covid vaccine works against UK, South Africa variantsWhile the findings indicated no need for a new vaccine to tackle the new strains, Pfizer and BioNTech said they would respond if there was ...
- China starts work on plant for mRNA-based COVID-19 vaccine candidate: MediaThe mRNA technology contains instructions for human cells to make proteins that mimic part of the coronavirus, and is used in vaccines from...
- Pfizer's coronavirus vaccine isn't expected to reach India anytime soon; US, UK first in lineThe extremely stringent temperature requirement for mRNA vaccines, which is what the Pfizer vaccine candidate is based on, will also make i...
- Pfizer, BioNTech start combined trials of COVID-19 vaccine candidate in JapanThe study will recruit 160 people aged 20 to 85, the companies said in a statement.
- GSK collaborates with Germany's CureVac, set to take 10% stake for $163 millionBritain's GSK said on Monday it would invest 130 million pounds ($163 million) in German biotech firm CureVac for a 10% stake to work toget...
Load More
